Developing a Logo Therapy Focused Program for Individual with Common Variable Immunodeficiency Disease (CVID): Efficacy on Resilience and Quality of Life

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210202050218N1

Enrollment

Registered

2021-02-20

Start date

2021-02-20

Completion date

Unknown

Last updated

2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Common Variable Immunodeficiency.

Interventions

Intervention 1: Before the intervention, the online pre-test is performed and the questionnaires are sent to the patients as a link. LogoTherapy is performed in 10 sessions of 90 minutes and online by

Eligibility

Sex/Gender

All

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Definitive diagnosis of CVID age between 18-45 years at least 3 years after diagnosis and initiation of IVIG blood transfusion Minimum diploma education Satisfaction to participate in research

Exclusion criteria

Exclusion criteria: diagnosis of psychotic disorders

Design outcomes

Primary

Measure	Time frame
Resilience. Timepoint: Before the intervention, after the end of the intervention, 1 month after the end. Method of measurement: Connor & Davison Resilience Questionnaire (CD_RSC).;Quality of Life. Timepoint: Before the intervention, after the end of the intervention, 1 month after the end. Method of measurement: Common Variable Immune Deficiency Quality of Life Questionnaire (CVID_QoL).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShaghayegh Kahrizi

University of Tehran

kahrizi_1364@yahoo.com+98 31 3221 7361

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026